# A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

> **NCT00544986** · PHASE4 · COMPLETED · sponsor: **AstraZeneca**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Anastrozole

## Key facts

- **NCT ID:** NCT00544986
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** — (—)
- **Last updated:** 2013-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00544986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00544986, "A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00544986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*